| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.071 | 0.03 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.099 | 0.03 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.34 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.098 | 0.03 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.03 |